DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

34.25 -0.08 (-0.23%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RHHBY $34.25 -0.23%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.37
Previous Close $34.33
Daily Range $34.10 - $34.56
52-Week Range $32.08 - $38.15
Market Cap $192.5B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.6%)
Volume 1,433,119
Average Daily Volume 1,512,145
Current FY EPS $1.88

Sector

Healthcare

Industry

Pharma

Roche Holding Ltd. (ADR) (RHHBY) Description

Website:

News & Commentary Rss Feed

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

Why ImmunoGen Inc. is Soaring Higher Today

Takeda Pharmaceutical has licensed ImmunoGen's antibody-drug conjugate technology.

This Market Could Grow 6250% in 10 Years

With the regulatory pathway cleared, the biosimilars market is poised to turn into a gold mine, growing up to 6,250% in 10 years. Here's where to stake your claim.

Dividend Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers up two dividend-paying healthcare stocks to avoid and one that could be a good buy for long-term income investors.

Why Prothena Corporation Plc is Soaring Higher Today

Results for Prothena's early-stage Parkinson's disease drug, PRX-002, have sent shares surging.

Why Inovio Pharmaceuticals Inc. Shot Higher Today

Despite reporting a net loss, Inovio's research pipeline opportunity boosts shares.

Why Exelixis, Inc. Shares Skyrocketed 57% in February

Exelixis shares soared in February as shareholders await two key catalysts.

Is Xoma Corporation A Buy?

Xoma Corporation could release late stage trial data that could significantly move the stock.

Why Pharmacyclics, Inc. Soared Higher Today

Pharmacyclics soars higher following reports that the company may put itself up for sale.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $34.25 (-0.23%)
Current stock: RHHBY
JNJ $100.34 (0.20%)
Current stock: JNJ
NVS $100.40 (0.84%)
Current stock: NVS
GSK $47.02 (0.77%)
Current stock: GSK